as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹15.35
Change
+0.23 (1.52%)
Open
₹15.19
Prev. Close
₹15.12
Day High
₹15.38
Day Low
₹15.05
Volume Analysis
Traded
224,755
Delivered
122,870
Delivery %
54.67%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹15.8 | ₹15.59 | ₹15.47 | ₹15.26 | ₹15.14 | ₹14.93 | ₹14.81 |
| Fibonacci | ₹15.59 | ₹15.46 | ₹15.39 | ₹15.26 | ₹15.13 | ₹15.06 | ₹14.93 |
| Camarilla | ₹15.44 | ₹15.41 | ₹15.38 | ₹15.26 | ₹15.32 | ₹15.29 | ₹15.26 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+2.06%
1 Week
+0.07%
1 Month
+8.87%
3 Months
+0.79%
6 Months
-2.42%
1 Year
+6.45%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Icicipramc - Val30ietf lands in the middle of the pack on TopFund's composite fundamentals check, at 55/100. The strongest factor is Risk & Volatility (72/100), while Liquidity (34/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
55/100 — AverageData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Which Mutual Funds Hold Icicipramc - Val30ietf?
Frequently Asked Questions about Icicipramc - Val30ietf
Icicipramc - Val30ietf (VAL30IETF) closed at ₹15.35 on NSE on 19 November 2026, up 0.23 (1.52%) from the previous close.
Icicipramc - Val30ietf trades on the NSE (National Stock Exchange of India) under the symbol VAL30IETF.
Icicipramc - Val30ietf has a TopFund Quality Score of 55/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Icicipramc - Val30ietf?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.